Plants and microbes as drug targets
1 / 108

Plants and microbes as drug targets - PowerPoint PPT Presentation

  • Updated On :

Plants and microbes as drug targets . Prof. H.S. Prakash Department of Biotechnology University of Mysore Manasagangotri, Mysore 570 006 . Higher plants – a rich source of novel compounds. 400,000 higher plant species 10% characterized chemically

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
Download Presentation

PowerPoint Slideshow about 'Plants and microbes as drug targets' - marlie

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Plants and microbes as drug targets l.jpg
Plants and microbes as drug targets

Prof. H.S. Prakash

Department of Biotechnology

University of Mysore

Manasagangotri, Mysore 570 006

Higher plants a rich source of novel compounds l.jpg
Higher plants – a rich source of novel compounds

  • 400,000 higher plant species

  • 10% characterized chemically

  • One-fourth of pharmaceuticals derived from plants

  • 11% of the 252 basic and essential drugs (WHO) are exclusively derived from flowering plants

  • Plant-derived drugs have huge market value US$30 billion in USA (2002)

Natural metabolites l.jpg
Natural metabolites

  • Secondary metabolites have no recognized role in maintaining fundamental life processes but have important role in the interaction of the cells with its environment

  • Only half the structures elucidated

  • Chemically highly diverse but characteristic of a plant

Role of secondary metabolites l.jpg
Role of secondary metabolites

  • Not clear

  • Important for survival of the plants in its ecosystem

  • Antimicrobial, anti-insect, deter potential predators

  • Discourage competing plant species

  • Attract pollinators or symbionts

  • Flovours, fragrances, dyes, pesticides and pharmaceuticals

Major groups l.jpg
Major groups

  • Based on biosynthetic origins structurally divided into five major groups

  • Polyketides: Acetate-mevalonate

  • Isoprenoids:Terpenoids and steroids from 5-C precursor isopentenyldiphosphate (IPP)

  • Alkaloids: via classical mevalonate pathway or the novel MEP (non-mevalonate or Rohmer) pathway

  • Phenylpropanoids: having C6-C3 units from aromatic amino acids phenylalanine or tyrosine

  • Flavonoids: combination of phenylpropanoids and polyketides

Biosynthetic pathways l.jpg
Biosynthetic pathways

  • Often long, complex multi-step events catalyzed by various enzymes and still largely unknown

  • Alkaloid biosynthesis: Best studied, 12,000 structures are known

  • Production of specific alkaloid: Often restricted to certain plant families

  • Flavonoids are abundant in many plant species

Examples natural drugs l.jpg
Examples – Natural drugs

  • Vinblastine, vincristine: Madagaskar periwinkle – Catharanthus roseus

  • Anticancer – Paclitaxel (Taxol), podophyllotoxin, camptothecin

  • Analgesic – Morphine

  • Semi-synthetic drugs – steroidal hormones derived from diosgenin – Dioscorea; corticosteroids, contraceptives, sex hormones

Plant chemical diversity l.jpg
Plant chemical diversity

  • Much greater than any chemical library

  • Enormous reservoir

  • ‘Omics’-based – functional genomics – screening

  • Limited success of combinatorial chemistry or computational drug design

Combinatorial chemistry l.jpg
Combinatorial chemistry

  • Designed organic chemistry enables optimization of molecular structures – Not attractive

  • 1981-2002: 28% (351) of 1031 new drug entities (NDEs) either natural products or derivatives

  • 24% synthesized based on natural resources

  • Major group: Anti-microbial (66%), Anti-cancer (52%), Anti-hypertensive, Anti-inflammatory

Plant cell culture an alternative production system l.jpg
Plant cell culture – an alternative production system

  • Plants are difficult to cultivate or becoming endangered

  • Chemical synthesis – complex structure/specific stereochemical requirements

  • Cell or organ culture: attractive alternative

  • But limited commercial success because of empirical nature of selecting high-yielding, stable cultures and lack of biosynthetic pathway and its regulation

Cell cultures l.jpg
Cell cultures

  • Production limitation

  • Treatment of undifferentiated cells with elicitors such as methyljasmonate, salicylic acid, chitosan and heavy metals

  • Organ culture: Hairy root (alkaloids) or shooty teratoma (tumor-like) cultures monoterpenes

Cell suspension cultures l.jpg
Cell suspension cultures

  • Shikonin from Lithospermumerythrorhizon

  • Berberine from Coptis japonica

  • Rosmarinin acid from Coleus blumeii

  • Sanguinarine from Papaversomniferum

  • Paclitaxel from Taxusbrevifolia

  • Bottlenecks – low productivity, process technological issues (Bioreactor design, cultivation conditions)

  • Functional genomics – Newer opportunities

Metabolic engineering strategies l.jpg
Metabolic engineering strategies

  • Decrease the catabolism of the desired compound

  • Enhance the expression or activity of a rate-limiting enzyme

  • Prevent feedback inhibition of a key enzyme

  • Enhance expression or activity of all genes involved in the pathway

  • Compartmentalization of the desired compound

  • Conversion of an existing product into a new product

Metabolic engineering strategies14 l.jpg
Metabolic engineering strategies

  • Gain-of-function and loss-of-function of genes

  • Discovery of transcription factors that regulate the entire pathway

  • Overexpression of transporters

  • Eg. Overexpression of rate-limiting upstream enzyme putrescine N-methyltransferase (PMT) and the downstream enzyme hyoscyamine 6β-hydroxylase (H6H) of tropane alkaloid biosynthesis enhanced production of scopolamine in cultivated hairy roots

Transcriptional regulation l.jpg
Transcriptional regulation

  • Part of terpenoidindole alkaloid biosynthesis in Catharanthusroseusis under the control of ORCA3, a jasmonate-responsive APETALA2 (AP2)-domain transcription factor

  • Constitutive overproduction of ORCA3 – enhanced terpenoidindole alkaloids

  • Maize transcription factors LC and C1 in tomato fruits upregulated the flavonoid pathway – kaempferol

  • ANT1 - Anthocyanin biosynthesis, glycosylation and transport in vacuoles

Transporters l.jpg

  • Nicotine and other alkaloids are exported by overexpressed yeast ABC transporter PDR5 in transgenic tobacco thus decreasing cellular toxicity

  • Multidrug resistance protein cjMDR1 obtained from berberine-producing Coptis japonica cells functions as an ABC transporter – probably pumps berberine into xylem cells for root-to-rhizome translocation

Functional genomics and secondary metabolites l.jpg
Functional genomics and secondary metabolites

  • Transcriptomics, proteomics, metabolomics

  • Genomics tools for medicinal plants are limited

  • Tools: 2-D gel electrophoresis-based proteomics, transcript analysis tools such as differential display, EST databases, micro-arrays

Possible functional genomics approach l.jpg
Possible functional genomics approach

  • High-throughput selection and testing of genes

  • Could be used without pre-existing sequence knowledge

  • Profiling methods (e.g. micro-arrays) require genomic information, hence cannot be used

Functional genomic approach l.jpg
Functional genomic approach

  • Elicit the metabolites (e.g. methyl jasmonate)

  • Use Genome-wide transcript profiling methods to identify expressed genes

  • Combining cDNA-amplified fragment length polymorphism, transcript profiling and targeted metabolic profiling in a time course experiment following elicitation, 591 genes out of 20,000 visualized genes were identified

Functional genomic approach22 l.jpg
Functional genomic approach

  • Homology searches: 58% genes had known function

  • Include Nicotine biosynthesis genes ornithine decarboxylase (ODC), arginine decarboxylase (ADC), quinolinate acid phosphoribosyl transferase (QPT) and many novel genes – alkaloid biosynthesis

  • Also putative proteins of unknown function (15%), signal transduction proteins such as receptors, kinases, phosphatases and transcription factors

High throughput functional analysis l.jpg
High-throughput functional analysis

  • Isolation of full-length cDNAs.

  • High-throughput construction of expression vectors

  • Developing a rapid transformation system

  • Downscaling the plant cell cultures

  • Rapid targeted metabolite profiling

  • Quantitative analysis of desired compounds

Problems in characterizing plant metabolome l.jpg
Problems in characterizing plant metabolome

  • Highly complex nature and chemical diversity

  • Range of chemical properties

  • Far more complex than metabolite profiling of primary metabolites

New lead molecules through combinatorial biochemistry l.jpg
New lead molecules through combinatorial biochemistry

  • Major classes of secondary metabolites (Polyketides, isoprenoids, alkaloids, phenylproponoids and flavonoids) subdivided into several subclasses

  • Eg. 12,000 known alkaloids subdivided into 15 subclasses: proto-, piperdine-, pyrrolidine-, pyridine-, quinolizidine-, trophane-, pyrrolizidine-, imidazole-, purine-, quinoline-, isoquinoline-, quinazoline-, indole-, terpenoid- and steroidal-alkaloids

Combinatorial biochemistry l.jpg
Combinatorial biochemistry

  • Secondary metabolites belonging to the same subclass are not always synthesized from the same primary metabolites but their chemical structures share the same basic skeleton

  • Because of activity of enzymes with different substrate- and stereo-specificity, the chemical diversity and biological activity of the molecules belonging to the same subclass can be enormous

  • Some subclasses are found only in a few plant familites (e.g. tropane alkaloids found in only Solanaceae and Erythroxylaceae), whereas flavonoids are widely distributed

Combinatorial biochemistry27 l.jpg
Combinatorial biochemistry

  • Different plants synthesize structurally similar but nevertheless diverse molecules

  • An enzyme isolated from one plant might encounter new but related substrates when introduced into another plant

  • Hybrid – new secondary metabolites

  • Somatic hybrids – Solanumbrevidensx S.tuberosum, both produce glycoalkaloid precursor teinemine – converted by a hydrogenase to tomatidine in S. brevidens and solanidineglycoalkaloid in S. tuberosum

  • Hybrid produced tomatidine and solanidine, also novel glycoalkaloid called demissidine

Yeast cell factories l.jpg
Yeast cell factories

  • Biocatalysts – biotransformation – organic synthesis

  • Major synthetic technologies based on biocatalytic reactions

  • Fermentation: A biological method resulting in products which are the result of the complex metabolism of microorganisms starting with inexpensive simple C and N sources

  • Enzymation (microbial transformation, microbial conversion, biotransformation, bioconversion): Living cells not necessary but only act as ‘simple bag of enzymes or catalysts’ – one or few-step

Alternative yeast l.jpg
Alternative yeast

Candida, Cryptococcus, Geotrichum, Issatchenkia, Kloeckera, Kluyveromyces, Pichia (including Hansenula polymorpha = P. angusta), Rhodotorula, Rhodosporidium, Schizosaccharomyces pombe, Torulopsis, Trichosporon, Trigonopsis variabilis, Yarrowia lipolytica and Zygosaccharomyces rouxii

Generation of designed microorganisms l.jpg
Generation of designed microorganisms

  • Increasing number of sequenced genes and whole genomes

  • New bioinformatic tools for analyzing the wealth of information

  • Biochemically well-characterized biosynthetic pathways

  • Well established genetic engineering techniques

Designed microorganisms genetic engineering approaches l.jpg
Designed microorganisms(Genetic engineering approaches)

  • Construction of synthetic pathways for the production of structurally complex, natural products like isoprenoids or polyketides

  • Delete harmful genes

  • E. coli, B. subtilis, Schizosaccharomyces pombe (fission yeast)

Chemical reactions catalyzed by wild type yeast whole cell biocatalysts l.jpg
Chemical reactions catalyzed by wild-type yeast whole-cell biocatalysts

  • Baker’s yeast (S. cerevisiae): Ideal as stereo-selective biocatalysts – chiral intermediates in the synthesis of enantiomerically pure compounds

  • Non-pathogenic, inexpensive, simple to grow at large scale, cells can be stored indefinitely in dried form

Main enzymatic reactions performed by wild type yeast l.jpg
Main enzymatic reactions performed by wild-type yeast biocatalysts

Reduction of C=O bonds

  • Asymmetric reduction of carbonyl-containing compounds (E.g. Furfural to furfuryl alcohol)

  • Reduces simple aliphatic and aromatic ketonesresulting in (S)-alcohols

  • Whole-cell (redox)-biocatalysts contain necessary cofactors and metabolic pathways

  • Cheap C sources (glucose, saccharose)

  • Biocatalysts and cofactors are well protected – more stable

  • Substrates – non-natural – toxic (0.3% per volume)

  • Large amounts of biomass and by-products – impede product recovery

  • Transport phenomenon

Wild type yeast l.jpg
Wild type yeast biocatalysts

  • Different strains – different specificities

  • Different dehydrogenaseswith overlapping substrate specificities but opposite stereoselectivities

  • Variety of oxidoreductases

  • Improved selectivity: substrate modification, changes in cultivation conditions, application of different C-sources, use of inhibitors, two-phase systems, water immiscible ionic liquids, biocompatible solvents to provide substrate reservoir and in situ extracting agent

Reduction of c c bonds l.jpg
Reduction of C=C-bonds biocatalysts

  • Flavin-depredox enzyme in yeast (Warburg and Christian, 1933)

  • Known as ‘old yellow enzymes’ (Flavin cofactor)

  • Typical substrates are alkenes ‘activated’ by electron-withdrawing substituents

  • Reduced at the expense of NAD(P)H leading to enantiomerically pure alkanes creating two chiral carbon centers

  • Excellent stereoselectivities

  • Cells provide both enoatereductaseand alcohol dehydrogenases, both depend on the same nicotinamide cofactor

  • E.g. asymmetric bioreductions of α,β-unsaturated ketones with S. cerevisiaeled to (R)-2,2,6-trimethylcyclohexane-1,4-dione used for 3-hydroxycarotenoid production

Oxidation and racemization reactions l.jpg
Oxidation and biocatalystsracemization reactions

  • Yeast alcohol oxidases– oxidation of methanol and other primary alcohols

  • Instead of creating a chiral center, it is ‘destructed’, hence limited synthetic use except for regioselective oxidation of polyols

  • Oxidation of sulfides can result in chiralsulfoxides used in organic synthesis as asymmetric auxilliary groups to control the stereochemical outcome

Hydrolase reactions l.jpg
Hydrolase reactions biocatalysts

  • Hydrolysis reactions – proteinases, lipases, esterases

  • Converted 1-alkyn-3-yl acetates to corresponding alcohols and acceptable enantioselectivities

Formation of c c bonds l.jpg
Formation of C-C-bonds biocatalysts

  • Acyloin condensation forms (1R)-phenylacetylcarbinol, a chiralsynthon of D-ephedrine

  • Involve pyruvatedecarboxylase

  • Benzaldehyde subjected to acyloid condensations

  • Conversion of α,β-unsaturated aldehydes giving optically active diols and production of the α-14 chromanyl moiety of α-tocopherol (Vit E)

Industrial application of yeast whole cell l.jpg
Industrial application of yeast whole-cell biocatalysts

  • Combining microbiological and chemical synthesis

  • E.g. S. cerevisiae: Acyloin-type condensation of benzaldehyde resulting in (1R)-phenylacetylcarbinol which is subsequently converted to (1R, 2S)-ephedrine and (1R,2S)-pseudoephedrine

  • Candida rugosa enoyl-CoA hydratase catalyzes butyric acid to (R)-β-hydroxy-n-butyric acid

  • Zygosaccharomyces rouxii: enantioselective reduction of 3,4-methylenedioxy-phenylacetone to the corresponding (S)-alcohol (Eli Lilly)

Industrial application of yeast whole cell44 l.jpg
Industrial application of yeast whole-cell biocatalysts

  • Pichia methanolica (Bristol-Myers Squibb): Reductase for the reduction of ethyl5-oxo-hexanoate and 5-oxo-hexanenitrile to the corresponding (S)-alcohols

  • Phenylalanine dehydrogenase from Thermoactinomyces intermedium used to produce Chiral intermediates for the production of antihypertensive drug, Omapatrilat

Recombinant yeasts l.jpg
Recombinant yeasts biocatalysts

  • Designer yeasts for biocatalytic applications

  • Metabolic engineering for heterologous protein production, extension of substrate range, pathways leading to new products, pathways for the degeneration of xenobiotics, engineering of cellular physiology for process improvement, elimination/reduction of by-product formation and improvement of yield or productivity

  • Production of high value chemicals – ethanol, glycerol, xylitol, succinic acid and other organic acids

Engineered yeast platform l.jpg
Engineered yeast platform biocatalysts

  • Mostly for chiral precursors for the pharmaceutical, food or feed industry including single- and multi-step biocatalytic reactions

  • Pathway engineering leading to structurally complex natural products

Organic single or few step transformations l.jpg
Organic single or few-step transformations biocatalysts

  • Optically pure ethyl (R)4-chloro-3-hydroxybutanoate from prochiral β-keto ester

  • Altered oxidoreductases – combining gene deletion and overexpression

  • GRAS status: Improved synthesis of the food flavoring methyl benzoate by expressing the Antirrhinum majus benzoid acid methyltransferase (BAMT) under the control of Cu-inducible CUP1 promoter

  • By encoding β-glucosidase in yeast elevated the resveratrol content

  • Expression of cyclohexanone monooxygenase from the Acinetobacter in S. cerevisiae – variety of substituted cycloalkanones and several sulfides, dithianes and dithiolanes

Cofactor regeneration l.jpg
Cofactor regeneration biocatalysts

  • For asymmetric reductions cofactor-dep enzymes are required

  • Considering the cost of NAD(P)+ and NAD(P)H, their stoichiometric application is not economically feasible

  • Whole-cell biocatalysts provide the cheapest cofactor regeneration system

  • Introduced membrane-bound transhydrogenase from E. coli

Transport limitations and displaying enzymes on the surface l.jpg
Transport limitations and displaying enzymes on the surface biocatalysts

  • Permeabilization protocols include solvent, detergent, alkaline treatment, air-drying at 42C

  • Molecular engineering – outer membrane structure (only for bacteria) or displaying enzymes on the cell surface

  • Molecular displaying: targeting of heterologous proteins to the surface of yeast

  • Hydrolases: Rhizopus oryzae lipase, β-glucosidases from A. oryzae

Synthetic pathways in yeasts l.jpg
Synthetic pathways in yeasts biocatalysts

  • Natural products like isoprenoids, flavonoids or polyketides are structurally complex

  • Great commercial potential

  • Carotenoids – antioxidants

  • Steroids – anti-inflammatory, contraceptive and anticancer agents

  • Terpenoids – diterpenoid taxol against cancer

  • Flavonoids derived from the phenylpropanoid pathway – anti-allergenic, anti-inflammatory, anti-oxidant

  • Polyketides – cancer (adriamycin), cardiovascular diseases (lovastatin), immunosuppression (rapamycin, tacrolimus) or infectious diseases (erythromycin, tetracycline)

Taxol l.jpg
Taxol biocatalysts

  • Isoprenoid (terpenoid)

  • Bark of Pacific yew (Taxus brevifolia)

  • Refractory ovarian and metastatic breast cancer

  • E. coli: Taxadiene (a taxol biosynthetic intermediate) – limitation can not functionally express the P450 enzymes

  • S. cerevisiae

Slide58 l.jpg

Taxol (1), the world’s first billion biocatalysts

dollar anticancer drug

Microbial factories for recombinant pharmaceuticals l.jpg
Microbial factories for recombinant pharmaceuticals biocatalysts

  • 151 recombinant pharmaceuticals approved by FDA and/or European Medicines Agency (EMEA) – bacteria or yeast

  • In spite of lack or unconventional post-translational modifications, proteolytic instability, poor solubility and activation of cell stress responses

Slide64 l.jpg

A large number of secondary metabolites have been extracted, isolated and characterized from endophytic microbes, especially from fungal endophytes

Slide65 l.jpg

Camptothecin was first isolated from the wood of isolated and characterized from endophytic microbes, especially from fungal endophytesCamptotheca acuminata.

Camptothecin has been obtained from fungal endophytes isolated from the inner bark of the plant Nothapodytes foetida from the western coast of India.

Some alkaloids produced by endophytic fungi are also anticancer agents.

Wagenaar et al. isolated three novel cytochalasins from an endophyte Rhinocladiella sp. with potential antitumor activity against selected neoplastic cell lines

Rubrofusarin B is cytotoxic to the colon cancer cell line SW1116 (IC5O: 4.5 μg mL-1), and aurasperone A (18) is inhibitory to xanthine oxidase (XO) (IC50: 10.9 μM).

Rubrofusarin B fonsecinone A, asperpyrone B and aurasperone A by fractionation of the extract of Aspergillus niger IFB-E003, an endophyte of Cynodon dactylon.

Slide66 l.jpg

Guignardic acid was detected in the culture broth of an endophytic Guignardia sp. obtained from Spondias mombin

Xanthoviridicatin E and F are two novel quinine related metabolites produced by an endophytic Penicillium chrysogenum colonizing an unidentified plant. These metabolites inhibit the cleavage reaction of HIV-1 integrase with IC50 values of 6 and 5 uM, respectively

Phomol is a novel polyketide lactone from Phomopsis sp., present in the medicinal plant Erythrina crista-galli

Microcarpalide, a novel microfilament disrupting agent with weak cytotoxicity to mammalian cells, was characterized from an unidentified fungus in Ficus microcarpa

Slide70 l.jpg

A new anti-inflammatory compound, 5, 7-dimethoxy- 4- Anti-bacterialp- ethoxylphenylcoumarin (118), and 5, 7-dimethoxy-4-phenylcoumarin (119) were isolated from endophytic Streptomyces aureofaciens CMUAc130

Slide71 l.jpg

Anti-viral metabolites: Four new cyclohexadepsipeptides, pullularins A–D (120-123), were isolated from the endophytic fungus Pullularia sp. BCC 8613. Pullularin A exhibited activities against the malaria parasite Plasmodium falciparum K1 (IC50 3.6 μg mL-1) and herpes simplex virus type 1

Molecular farming pharming l.jpg
Molecular farming/’pharming’ pullularins A–D (120-123), were isolated from the endophytic fungus

  • Application of molecular biological techniques to the synthesis of commercial products in plants

  • CHO: Amylose-free starch, high amylose starch, cyclodextrins, fructans, trehalose

  • Lipids: Medium-chain fatty acids, saturated fatty acids, mono-unsaturated fatty acids, polyhydroxybutyrate

Molecular farming of proteins l.jpg
Molecular farming of proteins pullularins A–D (120-123), were isolated from the endophytic fungus

  • Antibodies – full Igs and engineered types such as scFVs (single chain antibodies)

  • Subunit vaccines – vaccines based upon short peptide sequences that act as antigens

  • Protein antibiotics

Examples of enzymes produced in plants l.jpg
Examples of enzymes produced in plants pullularins A–D (120-123), were isolated from the endophytic fungus

  • Avidin: diagnostic kits

  • β-glucuronidase: diagnostics kits

  • Trypsis: wound care

  • Cellulase: Ethanol production

  • Thermostable xylanase: Biomass processing

  • Phytase: food processing

  • (1-3)(1-4)β-glucanase: Brewing

  • Lignin peroxidase: Paper manufacture

Biopharmaceutical recombinant proteins l.jpg
Biopharmaceutical recombinant proteins pullularins A–D (120-123), were isolated from the endophytic fungus

  • Protein C: Anticoagulant

  • Hirudin: Anticoagulant

  • Somatotrophin: Growth hormone

  • β-interferon: Hepatitis B + C

  • Serum albumin: Burns/fluid replacement

  • Haemoglobin-α and – β Blood substitute

  • Homotrimeric collagen: Collagen

  • α1 – antitrypsin: cystic fibrosis, haemorrhages

  • Aprotinin (trypsin inhibitor): Transplant surgery

  • Lactoferrin: Antimicrobial

  • ACE: Hypertensis

  • Trichosanthin- α : HIV therapy, cancer

Slide76 l.jpg

List of plants with anti-diabetic activity pullularins A–D (120-123), were isolated from the endophytic fungus

Aegle marmelos


Gymnema sylvestre

Salacia petenensis

Slide77 l.jpg

List of plants with anti-inflammatory activity pullularins A–D (120-123), were isolated from the endophytic fungus

Curcuma longa

Boswellia serrata

Ricinus communis 

Slide78 l.jpg

List of plants with anti-cancer activity pullularins A–D (120-123), were isolated from the endophytic fungus

Nothapodytes nimmoniana

Aphanamixis polystachya

Dioscorea bulbifera

Taxus brevifolia

Slide79 l.jpg

List of plants with pullularins A–D (120-123), were isolated from the endophytic fungus cardiotonic activity



Sida cordifolia

Rhamnus purshiana

Slide80 l.jpg

List of plants with anti viral activity pullularins A–D (120-123), were isolated from the endophytic fungus

Morinda charantia




Andrographis panniculata

Phyllanthus niruri

Slide81 l.jpg

BIOCHEMICAL ASSAYS pullularins A–D (120-123), were isolated from the endophytic fungus

Slide82 l.jpg

TLC Visualization Reagents pullularins A–D (120-123), were isolated from the endophytic fungus

Slide83 l.jpg

TLC PROFILES pullularins A–D (120-123), were isolated from the endophytic fungus

TLC profile of Piperine

Drug target assays l.jpg
Drug target assays pullularins A–D (120-123), were isolated from the endophytic fungus

  • Selectivity profiling

  • Target validation

  • Polymerases

  • HT screening (HTS)

  • Nuclear Receptors

  • Kinases

  • Phosphodiesterases

  • GPCRs

  • Transporters

  • Ion channels

  • Nitric oxide synthases

  • Dehydrogenases

  • Proteases

High throughput screening l.jpg
High throughput screening pullularins A–D (120-123), were isolated from the endophytic fungus

  • Convert primary assays into HTP

  • Large scale reagent preparation

  • Multiple methodologies and dependable results


    ELISA, RT-PCR, RIA, Particle agglutination, cell-based assays, cell culture, HPLC, Genomic sequence

Systems biology in drug discovery l.jpg
Systems biology in drug discovery pullularins A–D (120-123), were isolated from the endophytic fungus

  • Encompasses many different approaches and models for probing and understanding biological complexity

  • Develop predictive models of human disease

  • Principal approaches:

    Informatic integration of ‘omics’data sets (bottom up approach)

    Computer modeling of disease or organ system from literature (top-down approach to target selection, clinical indication and clinical trial design)

    Use of complex human cell system themselved to interpret and predict the biological activities of drugs and gene targets (direct experimental approach)

Slide87 l.jpg

Thank you pullularins A–D (120-123), were isolated from the endophytic fungus

Ion channels l.jpg
Ion channels pullularins A–D (120-123), were isolated from the endophytic fungus

  • Fluorometry

  • Electrophysiology

  • Radiometric binding assays

Gpcrs l.jpg
GPCRs pullularins A–D (120-123), were isolated from the endophytic fungus

  • HTP agonist, antagonist and pathway exploration

  • GPCR expressing cell lines and cDNAs

  • Calcium, cAMP readouts

  • Radio-labeled and label-free assays


    Ligand binding, receptor dimerization and downstream signalling

Selectivity profiling l.jpg
Selectivity profiling pullularins A–D (120-123), were isolated from the endophytic fungus

  • Determine mechanism of action and inhibitory profile of compounds

  • Protein kinase and phosphatase targets and disease specialized panels

Nuclear receptors l.jpg
Nuclear receptors pullularins A–D (120-123), were isolated from the endophytic fungus

  • HTP cellular reporter gene assay

  • Disease specific nuclear receptor panel screening

  • Biochemical FRET assays

Target validation l.jpg
Target validation pullularins A–D (120-123), were isolated from the endophytic fungus

  • Eliminate non-disease relevant targets

  • Functional assays and histology

  • Disease-specific assays

  • Eliminate non-relevant compounds

  • Angiogenesis, cancer models, nervous system assays

Proteases l.jpg
Proteases pullularins A–D (120-123), were isolated from the endophytic fungus

  • Proteases are one of the largest classes of potential drug targets with over 600 human gene targets and infectious diseases

  • Protease inhibitory activity

Transporters94 l.jpg
Transporters pullularins A–D (120-123), were isolated from the endophytic fungus

  • Small molecules that inhibit transporter activity in the kidney may improve drug half life

Dehydrogenases l.jpg
Dehydrogenases pullularins A–D (120-123), were isolated from the endophytic fungus

  • Targets for human parasites such as malaria, metabolic disorders, hormone imbalance and anti-angiogenesis

  • Measure oxidation of NADH via dehydrogenase activity

Other assays l.jpg
Other assays pullularins A–D (120-123), were isolated from the endophytic fungus

  • Polymerases

  • HERG channel screening assays

  • NAD/NADH assay

  • Neutrophil elastase release assay: Cell-based screening for anti-inflammatory drug

  • Nitric oxide synthases: inflammatory response to cancer and bacterial invasion

Toxicological assays l.jpg
Toxicological assays pullularins A–D (120-123), were isolated from the endophytic fungus

  • Mammalian toxicology: General, inhalation, reproduction, opthamologic, juvenile, dermal, phototoxicity, immunotoxicity

  • Cytotoxicity: Zebrafish embryos, epidermal cells, hematopoietic cells, hepatocytes, tubule epithelial cells, endothelial cells, cardiomyocytes

  • Genotoxicity: Ames test, chromosome aberration, comet assay, micronuclus test

  • Cardiotoxicity: HERG inhibition, cardiac channels, action potential duration, perfused heart

  • Safety pharmacology: Off-target effects, respiratory, cardiovascular, gastrointestinal, CAN (behaviour)

  • Drug-drug interaction

  • Clinical pathology

  • Anatomic pathology

Chemistry l.jpg
Chemistry pullularins A–D (120-123), were isolated from the endophytic fungus

  • Compound integrity: GC-MS, LC/MS, NMR, High resolution MS, elemental analysis, melting point, UV and IR profiling, Optic rotation

  • Natural products: screening, analysis, purification, fermenation

  • Chemical properties: Thermal analysis, aqueous solubility, chemical stability, partition coefficient, photostability

Groups of natural compounds l.jpg
Groups of natural compounds pullularins A–D (120-123), were isolated from the endophytic fungus

  • Natural compounds: Vincristine (leukemia)

  • Semisynthetic derivatives: Podophyllotoxin (cancer)

  • Basic skeleton –diosgenin – Dioscorea sp.

  • Steroid skeleton – corticosteroids, contraceptives, sex hormones

Production of nanoparticles l.jpg
Production of nanoparticles pullularins A–D (120-123), were isolated from the endophytic fungus

  • An array of physical, chemical and biological methods – synthetic nanomaterials

  • Particular shape and size

  • UV-radiation, aerosol techniques, lithography, laser ablation, ultrasonic fields, photochemical reduction techniques

  • Expertise and need hazardous chemicals

Production of nanoparticles using organisms green chemistry l.jpg
Production of nanoparticles using organisms (Green chemistry)

  • Unique potential in environmentally friendly production and accumulation of nanoparticles with different shapes and size

  • Different applied chemical composition, controlled monodispersity, desired morphologies, interested particle size

  • Biosynthesis of gold, silver, gold-silver alloy, selenium, platinum, palladium, silica, titanium, zirconia, quantum dots, magnetite etc.

  • Rate of synthesis slow

  • Optimize microbial cultivation methods, extraction techniques, combinatorial appraoch – photobiological methods

Comparing a cell to a factory l.jpg
Comparing a cell to a factory chemistry)

  • Plasma membrane like shipping/receiving department regulates what enters and leaves the cell, where cell makes contact with the external environment

  • Nucleus is like CEO controls all cell activity, determines what proteins will be made

  • Cytoplasm like factory floor contains the organelles, site of most cell activity

  • ER like assembly line where ribosomes do their work

  • Ribosomes like workers in the assembly line build the proteins

  • Golgi apparatus like finishing/packaging department prepare proteins for use or export

  • Lysosomes like maintenance crew responsible for breaking down and absorbing materials taken in by the cell

  • Cytoskeleton like support beams (walls, ceilings, floors) maintains cell shape

  • Mitochondria /chloroplasts like power plant transforms one form of energy into another

Examples l.jpg
Examples chemistry)

  • Sulfite reductase-mediated synthesis of gold nanoparticles capped with phytochelatin

  • Nitrate reductase-mediated synthesis of silver nanoparticles from silver nitrate

  • Facile biosynthesis, separation and conjugation of gold nanoparticles to doxorubicin

  • CdS quantum dots: Enzyme mediated in vitro synthesis, characterization and conjugation with plant lectins

  • Extracellular biosynthesis of CdSe quantum dots by Fusarium oxysporum